WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 70.00
0.00 (0.00%)
Jul 30, 2026, 11:23 AM CST
WeLeader Biomedical Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,143 | 1,109 | 991.13 | 940.7 | 1,036 | 841.14 |
Revenue Growth | 14.17% | 11.92% | 5.36% | -9.17% | 23.13% | - |
Gross Profit Gross Profit Growth | 389.24 | 370.97 | 316.32 | 298.08 | 291.75 | 218.92 |
Operating Income Operating Income Growth | 280.51 | 261.22 | 214.14 | 197.96 | 194.64 | 132.28 |
Net Income Net Income Growth | 220.57 | 208.56 | 170.21 | 152.28 | 153.8 | 105.77 |
Earnings Per Share EPS Growth | 4.61 | 4.52 | 4.08 | 3.71 | 5.05 | 3.76 |
EPS Growth | 16.59% | 10.89% | 9.97% | -26.53% | 34.31% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
The Company The Company Growth | 947.34 | 921.45 | 825.01 | 786.04 | 873.39 | 742.56 |
Health Leader Biomedical Co., Ltd. Health Leader Biomedical Co., Ltd. Growth | 200.63 | 192.86 | 166.38 | 155.57 | 165.55 | 102.42 |
Adjustments and Write-Offs Adjustments and Write-Offs Growth | -4.86 | -5.02 | -0.27 | -0.9 | -3.23 | -3.85 |
Total Total Growth | 1,143 | 1,109 | 991.13 | 940.7 | 1,036 | 841.14 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 357.36 | 334.71 | 212.17 | 104.95 | 111.45 | 118.71 |
Total Debt Total Debt Growth | 850.38 | 853.11 | 796.77 | 626 | 701.25 | 282.19 |
Net Cash (Debt) Net Cash Growth | -493.02 | -518.4 | -584.6 | -521.05 | -589.79 | -163.49 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -10.12 | -11.16 | -14.01 | -12.68 | -19.38 | -5.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 300.94 | 313.3 | 278.76 | 231.86 | 280.27 | 238.03 |
Capital Expenditures CapEx Growth | -181.93 | -212.74 | -170.71 | -114.73 | -659.36 | -21.6 |
Free Cash Flow Free Cash Flow Growth | 119.01 | 100.56 | 108.06 | 117.13 | -379.09 | 216.43 |
Free Cash Flow Growth | 0.15% | -6.94% | -7.75% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.05% | 33.44% | 31.92% | 31.69% | 28.17% | 26.03% |
Operating Margin | 24.54% | 23.55% | 21.61% | 21.04% | 18.79% | 15.73% |
Pretax Margin | 24.21% | 23.53% | 21.71% | 20.57% | 18.59% | 15.63% |
Profit Margin | 19.30% | 18.80% | 17.17% | 16.19% | 14.85% | 12.57% |
FCF Margin | 10.41% | 9.06% | 10.90% | 12.45% | -36.60% | 25.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.100 | 4.100 | 3.370 | 2.300 | 0.860 | 0.450 |
Dividend Per Share Growth | 21.73% | 21.66% | 46.52% | 167.44% | 91.11% | - |
Dividend Yield | 5.86% | 5.92% | 4.84% | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.17 | 16.01 | 19.05 | - | - | - |
P/FCF Ratio | 26.75 | 33.20 | 30.01 | - | - | - |
PS Ratio | 2.78 | 3.01 | 3.27 | - | - | - |